Novica | sloveniabusiness.eu
Summary
Saluss net profit up by a third in H1Ljubljana, 30 August (STA) - The group around the Ljubljana-based pharmaceutical wholesaler Salus generated EUR 321 million in net sales revenue in the first six months of the year, which is 11% more year-on-year. Its net profit increased year-on-year by around a third to EUR 6.8 million, the group said in the report published on Friday.The groups profit from regular operations and profit from regular operations before amortisation both increased by around a third to EUR 8.8 million and just under EUR 12.7 million, respectively.The group performed above plan in the first six months, Salus said. In the absence of unexpected or extraordinary events it expects to exceed the plans also at the annual level, which would have the group generate EUR 672 million in net sales revenue with a net profit of EUR 9 million.In January 2023, Salus signed a contract with several municipalities in the northeast to purchase Maribors pharmaceuticals wholesaler Farmadent. According to the newest report, the conditions were not met by January this year and so the contract was terminated. In March 2024 the companies signed an addendum providing for an adjusted buyers payment of EUR 564,772, with the possibility of further payments up to a maximum total of EUR 900,000 if the remaining conditions were met.